Fluticasone furoate, umeclidinium and vilanterol once-daily single inhaler triple therapy

Description

In this Product Explainer, Respiratory Physician Dr Adrian Barnett explains the role of fluticasone furoate, umeclidinium and vilanterol once-daily single inhaler triple therapy for the maintenance treatment of asthma in adult patients who are not adequately controlled with an ICS+LABA (5 mins).

This educational activity was developed by Healthed at the request of and with funding from GSK.

PM-AU-FVU-VID-240005 Approved September 2024.

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Dr Jo-Ann See

Dr Jo-Ann See

Management of Acne in Teens

Dr Robert Hungerford

Dr Robert Hungerford

An Update on Heart Failure in General Practice

A/Prof Daryl Cheng

A/Prof Daryl Cheng

Invasive Pneumococcal Disease – What GPs Need to Know

A/Prof Yvonne Zissiadis

A/Prof Yvonne Zissiadis

Innovations in Breast Radiation

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Dr Adrian Barnett

expert

Dr Adrian Barnett

Respiratory Physician, Gold Coast University Hospital

Date published: 12 November 2024